您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Tariquidar methanesulfonate,hydrate
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Tariquidar methanesulfonate,hydrate
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Tariquidar methanesulfonate,hydrate图片
CAS NO:625375-83-9
包装:500 mg
市场价:11717元

产品名称
XR9576 methanesulfonate, hydrate
Tariquidar methanesulfonate, hydrate
产品介绍

产品描述

Tariquidar methanesulfonate, hydrate is a potent and specific P-glycoprotein (P-gp) inhibitor(Kd of 5.1 nM).

体外活性

Tariquidar methanesulfonate, hydrate (XR9576 methanesulfonate, hydrate) is a potent P-gp mediated [3H]-Vinblastine modulator and [3H]-Paclitaxel transport as it increases the steady-state accumulation of these cytotoxics in CHrB30 cells to levels observed in non-P-gp-expressing AuxB1 cells with EC50 of 487±50 nM. [3H]-Tariquidar binds to CHrB30 membranes with the highest affinity with Kd of 5.1±0.9 nM, n=7 and a binding capacity (Bmax) of 275±15 pmol/mg membrane protein. In contrast to the parental cell line, the accumulation of [3H]-Vinblastine is increased in a dose-dependent fashion by the modulators XR9576 with EC50 of 487±50 nM. The MDR modulator Tariquidar is able to inhibit 60-70% of the vanadate-sensitive ATPase activity(IC50 of 43±9 nM)[1]. Tariquidar potentiates the cytotoxicity of several drugs including Doxorubicin, Paclitaxel, Etoposide, and Vincristine; complete reversal of resistance is achieved in the presence of 25-80 nM Tariquidar. Tariquidar is a potent inhibitor of photoaffinity labeling of P-gp by [3H]Azidopine implying a direct interaction with the protein[2].

体内活性

In mice with intrinsically resistant MC26 colon tumors, co-administration of hydrated Tariquidar mesylate (XR9576 mesylate, hydrate) can enhance the antitumor activity of doxorubicin without significantly increasing toxicity; maximum potentiation is observed at 2.5-4.0 mg/kg dosed either i.v. or p.o. In addition, coadministration of Tariquidar (6-12 mg/kg p.o.) fully restores the antitumor activity of Paclitaxel, Etoposide, and Vincristine against two highly resistant MDR human tumor xenografts (2780AD, H69/LX4) in nude mice. Tariquidar is found to also significantly potentiate the antitumor activity of doxorubicin against s.c. MC26 tumors in vivo[2].

Cas No.

625375-83-9

分子式

C40H52N4O15S2

分子量

892.99

别名

XR9576 methanesulfonate, hydrate;Tariquidar methanesulfonate, hydrate

储存和溶解度

DMSO:296 mg/mL (331.47 mM)
H2O:5 mg/mL (5.60 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years